Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Diabetes Mellitus, Type 1

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Diabetes Mellitus, Type 1 in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hyun, E1
Ramachandran, R1
Cenac, N1
Houle, S1
Rousset, P1
Saxena, A1
Liblau, RS1
Hollenberg, MD1
Vergnolle, N1
Lin, HY1
Tsai, CC1
Chen, LL1
Chiou, SH1
Wang, YJ1
Hung, SC1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Diabetes Mellitus, Type 1

ArticleYear
Insulin modulates protease-activated receptor 2 signaling: implications for the innate immune response.
    Journal of immunology (Baltimore, Md. : 1950), 2010, Mar-01, Volume: 184, Issue:5

    Topics: Animals; Calcium; Cell Line; Cells, Cultured; Chromones; Diabetes Mellitus, Type 1; Endothelial Cell

2010
Fibronectin and laminin promote differentiation of human mesenchymal stem cells into insulin producing cells through activating Akt and ERK.
    Journal of biomedical science, 2010, Jul-12, Volume: 17

    Topics: Blotting, Western; Cell Differentiation; Cell Line; Cell- and Tissue-Based Therapy; Chromones; Diabe

2010